Nearly three in four American voters (74 percent) favor increasing federal funding for cancer research, according to the results of a new national survey conducted on behalf of the American Association for Cancer Research (AACR). The survey results were released today in conjunction with the AACR’s fifth annual Cancer Progress Report. The report highlights how federally funded research can power progress against cancer and urges Congress and the administration to implement a strategy for providing annual budget increases of at least 7 percent for the National Institutes of Health (NIH), National Cancer Institute (NCI), and U.S. Food and Drug Administration (FDA) in fiscal year 2016 and thereafter.
The national survey, which was conducted by Hart Research Associates and Public Opinion Strategies, shows that five out of every six voters recognize what the AACR Cancer Progress Report 2015 details: that progress is being made against cancer.
To view the multimedia release go to:
http://www.multivu.com/players/English/7613551-aacr-cancer-research-survey/
As businesses become increasingly frustrated by shelf-life hardware and out-of-the-box software, hosted solutions have grown increasingly popular, with 81% of corporates already using or planning to use cloud-based services according to recent research.
42% of SMEs who subscribed to hosted services did so in the last 12 months, showing the swift emergence of cloud solutions.
To view Multimedia News Release, go to http://www.multivu.com/mnr/62395-TalkTalk-business-hosting-solutions
Lake Research Partners and Bellwether Research and Consulting recently released a new national poll sponsored by the American Motorcyclist Association (AMA) that finds likely 2016 voters have widespread and serious concerns about ethanol’s unintended consequences—including damage to engines, land conversion and food prices.
“Voters across party lines express grave concerns for the impacts of the corn ethanol mandate from the Renewable Fuel Standard that touch many parts of their lives from the cars they drive to the food they buy,” said Celinda Lake, president of Lake Research Partners. “They strongly support bi-partisan proposals that would reduce the impact of corn ethanol, and particularly support the Environmental Protection Agency reducing the amount of corn ethanol required by law.”
As the EPA recently closed the comment period on its proposed ethanol volumes for 2014, 2015 and 2016, the poll also shows that 67 percent of people favor the agency setting ethanol volumes below what is required by law, with 68 percent of Democrats and 71 percent of Republicans supporting volumes lower than the statute.
To view the multimedia release go to: http://www.multivu.com/players/English/7576751-ama-national-ethanol-voter-poll/
Lithium Technologies today announced the winners of the fifth annual Lithium Digital Customer Excellence Awards, affectionately known as the Lithys. This year’s awards set a new record for submissions with 66 entries from 17 countries across four continents and representing 47 brands. The 2015 Lithys also had a big impact on Lithium’s own community, generating more than 21,000 page views and 9,000 visits—and adding 4,000 community members during the voting period. Winners were determined by community votes, outside judges Nate Elliott from Forrester Research and Jim Storer of The Community Roundtable, and Lithium executives.
To view the Multimedia News Release, go http://www.multivu.com/players/English/7522751-lithy-2015-winners/
There is a growing body of evidence linking yogurt consumption to improved health, and additional research to identify the scientific link between yogurt and potential health benefits, is underway scientists say. International nutrition experts gathered at the First Global Summit on the Health Effects of Yogurt in Boston on April 24, 2013 to present the current state of the science on the health effects of yogurt and identify research gaps that need to be addressed within the scientific community.
To view Multimedia News Release, go to http://www.multivu.com/mnr/61206-american-society-nutrition-health-effects-yogurt-weight-chronic-disease
Newron Pharmaceuticals S.p.A. (“Newron”), a research and development company focused on novel CNS and pain therapies, and its partner Zambon S.p.A., an international pharmaceutical company strongly committed to the CNS therapeutic area, announced today that the EU Committee for Medicinal Pro-ducts for Human Use (CHMP) recommended that the European Commission approve the use of Xadago™ (safinamide) as add-on to L-dopa alone or in combination with dopamine agonists, entacapone, amantadine, and/or anticholinergics, for the treatment of patients with mid-late stage Parkinson’s disease experiencing motor fluctuations despite being stabilized on ‘Standard of Care’.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7406951-chmp-xadago-parkinsons/
Today, WebMD released The Cutting Edge of Cancer a five-part investigative video series developed in partnership with Robin Roberts and her independent production company, Rock’n Robin Productions. Through compelling patient stories and insights from medical experts, The Cutting Edge of Cancer, supported by Cancer Treatment Centers of America®, highlights some of the most promising areas of medical innovation in cancer care, including early detection, immunotherapy, genomic research, and integrative medicine.
To view the multimedia release go to:
http://www.multivu.com/players/English/7579755-webmd-robin-roberts-cutting-edge-of-cancer/
The TOEIC Program recently launched Why English Matters, a new content-based website that seeks to build awareness and share information about the important role that English-language proficiency plays in the global economy.
Why English Matters features a new video documentary series that explores the role of English through interviews with human resource managers and decision makers from leading global organizations. The site also features related research and news articles about the impact of effective English communication skills for the international workforce.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/7056051-ets-toeic-program-why-english-matters-website-documentary-series
Blood cancers are the third leading cause of cancer deaths in the U.S. However, many Americans are unaware of the impact of these cancers, including leukemia, lymphoma and myeloma, which affect the bone marrow, the blood cells, the lymph nodes and other parts of the lymphatic system.
A new survey commissioned by The Leukemia & Lymphoma Society (LLS) reveals more than four in five adults (82%) are surprised that blood cancers are the third leading cancer killer of Americans. Further, nearly four in five adults (78%) are surprised that acute lymphocytic leukemia (ALL) is the most common cancer in children and young adults under age 20.
To view the multimedia release go to:
https://www.multivu.com/players/English/8128551-lls-blood-cancer-awareness-month/
Today Safe Kids Worldwide released a new research report that found kids are getting into medicine at an alarming rate. Every minute of every day, a poison control center receives a call about a potential medicine poisoning for a child age five and under. And 67,000 times each year, or every eight minutes, a young child goes to the emergency room for medicine poisoning. This is a 30 percent increase over the past ten years.
In its report entitled An In-Depth Look at Keeping Young Children Safe Around Medicine, Safe Kids examines data from the U.S. Consumer Product Safety Commission, information from poison control centers and findings from several focus groups among moms. The report reviews what is happening in households that leads to these disturbing numbers and offers parents simple things they can do to protect their children.
To view Multimedia News Release, go to http://www.multivu.com/mnr/60845-safe-kids-worldwide-keeping-young-children-safe-around-medicine
Alimera Sciences, Inc. (NASDAQ: ALIM) (Alimera), a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, announced today that many retina specialists throughout the U.S. are now using ILUVIEN® (fluocinolone acetonide intravitreal implant) 0.19 mg to treat patients with diabetic macular edema (DME). The first injections of ILUVIEN in the U.S. were captured during a live web event attended by more than 250 eye care professionals. ILUVIEN is the first multiyear eye implant designed to deliver a continuous, submicrogram daily dose of steroid to the retina for 36 months with one injection. ILUVIEN is indicated for the treatment of DME in patients who have been previously treated with a course of corticosteroids and did not have a clinically significant rise in intraocular pressure (IOP).
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7496251-iluvien-dme/
Not-for-profit pension provider NEST (National Employment Savings Trust) is urging consumers to keep their passions alive into later life as one of their New Year resolutions. Its research suggests that over 65s often have better social lives than any other age group except the under 25s.
To view Multimedia News Release, go to http://www.multivu.com/mnr/64179-new-year-resolution-not-give-up-nest
